Puma Biotechnology (PBYI) Payables: 2017-2025
Historic Payables for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $6.4 million.
- Puma Biotechnology's Payables fell 14.96% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year decrease of 36.67%. This contributed to the annual value of $5.5 million for FY2024, which is 20.03% down from last year.
- As of Q3 2025, Puma Biotechnology's Payables stood at $6.4 million, which was up 17.74% from $5.4 million recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's Payables peaked at $20.0 million during Q3 2021, and registered a low of $5.1 million during Q3 2023.
- Its 3-year average for Payables is $7.4 million, with a median of $6.9 million in 2023.
- Per our database at Business Quant, Puma Biotechnology's Payables tumbled by 66.09% in 2023 and then skyrocketed by 73.19% in 2024.
- Over the past 5 years, Puma Biotechnology's Payables (Quarterly) stood at $11.2 million in 2021, then crashed by 42.37% to $6.4 million in 2022, then increased by 6.97% to $6.9 million in 2023, then dropped by 20.03% to $5.5 million in 2024, then decreased by 14.96% to $6.4 million in 2025.
- Its last three reported values are $6.4 million in Q3 2025, $5.4 million for Q2 2025, and $6.0 million during Q1 2025.